Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 from Investing in MAKO Surgical Corporation to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at MAKO Surgical Corporation (“MAKO” or the “Company”) (NASDAQ: MAKO).

The investigation focuses on whether MAKO and its executives violated federal securities laws by failing to disclose that:  (1) the Company was poised to suffer a larger first-quarter loss due to higher costs and slower sales of its RIO systems; (2) utilization rates were declining for the Company's RIO systems; and (3) the Company's 2012 outlook lacked a reasonable basis when made.

On May 7, 2012, MAKO announced its first quarter 2012 financial results. Although revenue rose from the first quarter 2011, it dropped approximately 40% from the fourth quarter 2011 and missed analysts' consensus expectations by approximately 20%. As a result, MAKO stock dropped $15.13 to close at $26.27 per share on May 8, 2012.

Take Action

If you purchased MAKO stock or options between January 9, 2012 and May 7, 2012 and would like to discuss your legal rights, contact us by calling Juan Monteverde, Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding ModusLinks’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.